Antag Therapeutics ApS

Antag Therapeutics ApS (CVR number: 38402056) is a company from KØBENHAVN. The company recorded a gross profit of -13707.6 kDKK in 2023. The operating profit was -16 mDKK, while net earnings were -13.8 mDKK. The profitability of the company measured by Return on Assets (ROA) was -63 %, which can be considered poor and Return on Equity (ROE) was -96.6 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -27.7 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Antag Therapeutics ApS's liquidity measured by quick ratio was 13.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.